Clinical Trial

Role of HbA1c in Predicting Adverse Pregnancy Outcomes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 6, 2024 (before its estimated June 26, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.
Trial Details
NCT Number NCT06676254
Lead Sponsor National University of Malaysia
Conditions Gestational Diabetes
Enrollment 195 participants
Start Date 2024-06-27
Primary Completion 2026-06-26 (estimated)
Study Completion 2026-06-26 (estimated)
Updated on ClinicalTrials.gov 2024-11-06